Cargando…

Liposomes as Carriers for the Delivery of Efavirenz in Combination with Glutathione—An Approach to Combat Opportunistic Infections

Human immunodeficiency virus (HIV)-infected individuals display an enhanced production of reactive oxygen species (ROS). This reduction of antioxidant capacity in host tissues has been related to the decrease in total levels of ROS scavengers such as glutathione (GSH). Prevention of opportunistic in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kenchappa, Vanaja, Cao, Ruoqiong, Venketaraman, Vishwanath, Betageri, Guru V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161618/ https://www.ncbi.nlm.nih.gov/pubmed/35663347 http://dx.doi.org/10.3390/app12031468

Ejemplares similares

General Overview of Nontuberculous Mycobacteria Opportunistic Pathogens: Mycobacterium avium and Mycobacterium abscessus
por: To, Kimberly, et al.
Publicado: (2020)

Elucidating the Efficacy of the Bacille Calmette–Guérin Vaccination in Conjunction with First Line Antibiotics and Liposomal Glutathione
por: Abrahem, Rachel, et al.
Publicado: (2019)

Liposomal Glutathione Helps to Mitigate Mycobacterium tuberculosis Infection in the Lungs
por: Kachour, Nala, et al.
Publicado: (2022)

The Effects of Oral Liposomal Glutathione and In Vitro Everolimus in Altering The Immune Responses Against Mycobacterium bovis BCG Strain in Individuals With Type 2 Diabetes
por: To, Kimberly, et al.
Publicado: (2021)

Characterizing the Effects of Glutathione as an Immunoadjuvant in the Treatment of Tuberculosis
por: Cao, Ruoqiong, et al.
Publicado: (2018)

Effects of Oral Liposomal Glutathione in Altering the Immune Responses Against Mycobacterium tuberculosis and the Mycobacterium bovis BCG Strain in Individuals With Type 2 Diabetes
por: To, Kimberly, et al.
Publicado: (2021)

Understanding the Relationship between Glutathione, TGF-β, and Vitamin D in Combating Mycobacterium tuberculosis Infections
por: Singh, Mohkam, et al.
Publicado: (2020)

The Synergistic Effects of the Glutathione Precursor, NAC and First-Line Antibiotics in the Granulomatous Response Against Mycobacterium tuberculosis
por: Teskey, Garrett, et al.
Publicado: (2018)

Effects of Glutathione Diminishment on the Immune Responses against Mycobacterium tuberculosis Infection
por: Cao, Ruoqiong, et al.
Publicado: (2021)

Development and Stability Studies of Novel Liposomal Vancomycin Formulations
por: Muppidi, Krishna, et al.
Publicado: (2012)

Liposomal Glutathione Supplementation Restores T(H)1 Cytokine Response to Mycobacterium tuberculosis Infection in HIV-Infected Individuals
por: Ly, Judy, et al.
Publicado: (2015)

Can formulation and drug delivery reduce attrition during drug discovery and development—review of feasibility, benefits and challenges
por: Basavaraj, S, et al.
Publicado: (2014)

Glutathione Modulates Efficacious Changes in the Immune Response against Tuberculosis
por: Abnousian, Arbi, et al.
Publicado: (2023)

Liposome-Based Antibacterial Delivery: An Emergent Approach to Combat Bacterial Infections
por: Ghosh, Rita, et al.
Publicado: (2023)

Unveiling the Mechanisms for Decreased Glutathione in Individuals with HIV Infection
por: Morris, Devin, et al.
Publicado: (2012)

Nanotechnology in Advanced Drug Delivery
por: Jain, Sanyog, et al.
Publicado: (2011)

Potential Role of Glutathione Antioxidant Pathways in the Pathophysiology and Adjunct Treatment of Psychiatric Disorders
por: Poladian, Nicole, et al.
Publicado: (2023)

Glutathione Supplementation as an Adjunctive Therapy in COVID-19
por: Guloyan, Vika, et al.
Publicado: (2020)

Albumin nanoparticles coated with polysorbate 80 as a novel drug carrier for the delivery of antiretroviral drug—Efavirenz
por: Jenita, Josephine Leno, et al.
Publicado: (2014)

Everolimus-induced effector mechanism in macrophages and survivability of Erdman, CDC1551 and HN878 strains of Mycobacterium tuberculosis infection
por: Cao, Ruoqiong, et al.
Publicado: (2021)

Glutathione synthesis is compromised in erythrocytes from individuals with HIV
por: Morris, Devin, et al.
Publicado: (2014)

Elastic liposomes as novel carriers: recent advances in drug delivery
por: Hussain, Afzal, et al.
Publicado: (2017)

Effects of ReadiSorb L-GSH in Altering Granulomatous Responses against Mycobacterium tuberculosis Infection
por: Islamoglu, Hicret, et al.
Publicado: (2018)

Mechanisms of Control of Mycobacterium tuberculosis by NK Cells: Role of Glutathione
por: Allen, Michael, et al.
Publicado: (2015)

Glutathione and growth inhibition of Mycobacterium tuberculosis in healthy and HIV infected subjects
por: Venketaraman, Vishwanath, et al.
Publicado: (2006)

Analysis of glutathione levels in the brain tissue samples from HIV-1-positive individuals and subject with Alzheimer's disease and its implication in the pathophysiology of the disease process
por: Saing, Tommy, et al.
Publicado: (2016)

Cyclic Peptide [R(4)W(4)] in Improving the Ability of First-Line Antibiotics to Inhibit Mycobacterium tuberculosis Inside in vitro Human Granulomas
por: Hernandez, Joshua, et al.
Publicado: (2020)

Antimycobacterial Effects of Everolimus in a Human Granuloma Model
por: Ashley, David, et al.
Publicado: (2020)

Liposomes-In-Hydrogel Delivery System Enhances the Potential of Resveratrol in Combating Vaginal Chlamydia Infection
por: Jøraholmen, May Wenche, et al.
Publicado: (2020)

The Role of Glutathione in Prevention of COVID-19 Immunothrombosis: A Review
por: Glassman, Ira, et al.
Publicado: (2023)

Glutathione PEGylated liposomes: pharmacokinetics and delivery of cargo across the blood–brain barrier in rats
por: Rip, Jaap, et al.
Publicado: (2014)

Aliskiren Hemifumarate Proliposomes for Improved Oral Drug Delivery: Formulation Development, In Vitro and In Vivo Permeability Testing
por: Kunamaneni, Priyanka, et al.
Publicado: (2022)

trans-Double Bond-Containing Liposomes as Potential Carriers for Drug Delivery
por: Giacometti, Giorgia, et al.
Publicado: (2017)

Flavonoid Mixture Inhibits Mycobacterium tuberculosis Survival and Infectivity
por: Cao, Ruoqiong, et al.
Publicado: (2019)

Investigating the Causes for Decreased Levels of Glutathione in Individuals with Type II Diabetes
por: Lagman, Minette, et al.
Publicado: (2015)

Plasma Bead Entrapped Liposomes as a Potential Drug Delivery System to Combat Fungal Infections
por: Fatima, Munazza Tamkeen, et al.
Publicado: (2022)

Liposomes-Based Drug Delivery Systems of Anti-Biofilm Agents to Combat Bacterial Biofilm Formation
por: Makhlouf, Zinb, et al.
Publicado: (2023)

Glutathione and Adaptive Immune Responses against Mycobacterium tuberculosis Infection in Healthy and HIV Infected Individuals
por: Guerra, Carlos, et al.
Publicado: (2011)

Prediction of plasma efavirenz concentrations among HIV-positive patients taking efavirenz-containing combination antiretroviral therapy
por: Huang, Sung-Hsi, et al.
Publicado: (2017)

Editorial: Causes for Increased Susceptibility to Mycobacterium tuberculosis – A Close View of the Immune System
por: Venketaraman, Vishwanath
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_na82vikkuipjtgh2mlk0jnchtv